174 related articles for article (PubMed ID: 10648471)
1. Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis.
Jones EA; Dekker LR
Gastroenterology; 2000 Feb; 118(2):431-2. PubMed ID: 10648471
[TBL] [Abstract][Full Text] [Related]
2. Opiate antagonist therapy for the pruritus of cholestasis: the avoidance of opioid withdrawal-like reactions.
Jones EA; Neuberger J; Bergasa NV
QJM; 2002 Aug; 95(8):547-52. PubMed ID: 12145394
[TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for intractable pruritus is contraindicated before an adequate trial of opiate antagonist therapy.
Neuberger J; Jones EA
Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1393-4. PubMed ID: 11692070
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of oral naltrexone treatment for pruritus of cholestasis, a crossover, double blind, placebo-controlled study.
Terg R; Coronel E; Sordá J; Muñoz AE; Findor J
J Hepatol; 2002 Dec; 37(6):717-22. PubMed ID: 12445410
[TBL] [Abstract][Full Text] [Related]
5. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study.
Wolfhagen FH; Sternieri E; Hop WC; Vitale G; Bertolotti M; Van Buuren HR
Gastroenterology; 1997 Oct; 113(4):1264-9. PubMed ID: 9322521
[TBL] [Abstract][Full Text] [Related]
6. Oral nalmefene therapy reduces scratching activity due to the pruritus of cholestasis: a controlled study.
Bergasa NV; Alling DW; Talbot TL; Wells MC; Jones EA
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):431-4. PubMed ID: 10459118
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral naltrexone on pruritus in cholestatic patients.
Mansour-Ghanaei F; Taheri A; Froutan H; Ghofrani H; Nasiri-Toosi M; Bagherzadeh AH; Farahvash MJ; Mirmomen S; Ebrahimi-Dariani N; Farhangi E; Pourrasouli Z
World J Gastroenterol; 2006 Feb; 12(7):1125-8. PubMed ID: 16534857
[TBL] [Abstract][Full Text] [Related]
8. Naltrexone: a case report of pruritus from an antipruritic.
Sullivan JR; Watson A
Australas J Dermatol; 1997 Nov; 38(4):196-8. PubMed ID: 9431714
[TBL] [Abstract][Full Text] [Related]
9. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis.
Bergasa NV; Schmitt JM; Talbot TL; Alling DW; Swain MG; Turner ML; Jenkins JB; Jones EA
Hepatology; 1998 Mar; 27(3):679-84. PubMed ID: 9500694
[TBL] [Abstract][Full Text] [Related]
10. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial.
Bergasa NV; Alling DW; Talbot TL; Swain MG; Yurdaydin C; Turner ML; Schmitt JM; Walker EC; Jones EA
Ann Intern Med; 1995 Aug; 123(3):161-7. PubMed ID: 7598296
[TBL] [Abstract][Full Text] [Related]
11. Opioid antagonists in the treatment of pruritus from cholestatic liver disease.
Terra SG; Tsunoda SM
Ann Pharmacother; 1998 Nov; 32(11):1228-30. PubMed ID: 9825091
[TBL] [Abstract][Full Text] [Related]
12. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients.
Setnik B; Roland CL; Goli V; Sommerville K; Webster L
J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone for cholestatic itch: a systematic review.
Murray-Brown FL
BMJ Support Palliat Care; 2021 Jun; 11(2):217-225. PubMed ID: 33692114
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases.
Metze D; Reimann S; Beissert S; Luger T
J Am Acad Dermatol; 1999 Oct; 41(4):533-9. PubMed ID: 10495371
[TBL] [Abstract][Full Text] [Related]
15. Trials of opiate antagonists for the pruritus of cholestasis: primary efficacy endpoints and opioid withdrawal-like reactions.
Jones EA
J Hepatol; 2002 Dec; 37(6):863-5. PubMed ID: 12445430
[No Abstract] [Full Text] [Related]
16. Acute opioid withdrawal on accidental injection of naltrexone.
Yeo M; Campbell V; Bonomo Y; Sawyer SM
J Paediatr Child Health; 2003; 39(4):315-7. PubMed ID: 12755943
[TBL] [Abstract][Full Text] [Related]
17. [Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients].
Brune A; Metze D; Luger TA; Ständer S
Hautarzt; 2004 Dec; 55(12):1130-6. PubMed ID: 15517116
[TBL] [Abstract][Full Text] [Related]
18. Antagonist treatment of opioid withdrawal translational low dose approach.
Mannelli P; Gottheil E; Van Bockstaele EJ
J Addict Dis; 2006; 25(2):1-8. PubMed ID: 16785213
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study.
Malekzad F; Arbabi M; Mohtasham N; Toosi P; Jaberian M; Mohajer M; Mohammadi MR; Roodsari MR; Nasiri S
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):948-50. PubMed ID: 19453814
[TBL] [Abstract][Full Text] [Related]
20. Pain as a complication of use of opiate antagonists for symptom control in cholestasis.
McRae CA; Prince MI; Hudson M; Day CP; James OF; Jones DE
Gastroenterology; 2003 Aug; 125(2):591-6. PubMed ID: 12891561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
